New software aims to simplify diabetes drug choices for doctors

NCT ID NCT07063420

Recruiting now Knowledge-focused Sponsor: Daniel Chernavvsky, MD Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 34 times

Summary

This pilot study tests a decision support system (software) that helps healthcare providers choose the best combination of diabetes drugs for adults with type 2 diabetes who are already on insulin. The study will enroll 18 participants and measure how well the tool improves blood sugar control. The goal is to see if the software can make treatment decisions easier and more effective.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES TREATED WITH INSULIN are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University of Virginia Center for Diabetes Technology
RECRUITING

Charlottesville, Virginia, 22903, United States

Contact

Contact

Contact

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

TYPE 2 DIABETES TREATED WITH INSULIN